ROZINA BAVARSADE OMIDI: Open Payments
NPI 1558952804 · FAIR OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 35 payments from 14 companies in 2025. Trend: 2023 $480 · 2024 $740 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $109 |
| Corcept Therapeutics | 5 | $106 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Lilly USA, LLC | 3 | $74 |
| Boston Scientific Corporation | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $58 |
| Amgen Inc. | 2 | $54 |
| PFIZER INC. | 2 | $43 |
| Exact Sciences Corporation | 2 | $35 |
Products named: Korlym, JOURNAVX, MOUNJARO, Ozempic, General - Pain Management, JARDIANCE, EVENITY, Rybelsus.
Industry payments across CA — which companies pay providers there.
